Product Information

FEBUXOSTAT 80 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2810 per EA under NDC 59651011430. Its NADAC has been published 132 times since Feb 14, 2024.

FDA first approved this application on Oct 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FEBUXOSTAT 80 MG TABLET

Febuxostat
$0.2810per EA

Strength

80 mg/1

NDC

59651011430

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

FEBUXOSTAT

Approval Type

Generic (ANDA)

FDA Application

ANDA210741

FDA Approved

10/25/2023

TE Code

AB

On Market Since

10/25/2023

Pharmacological Classes

Xanthine Oxidase Inhibitor
Xanthine Oxidase Inhibitors

Price Statistics

The NADAC for FEBUXOSTAT 80 MG TABLET has been published 132 times since Feb 14, 2024, and over the history we have for it it has declined 51.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2810 per EA
All-time high$0.5895 (Nov 13, 2024)
All-time low$0.2636 (Feb 18, 2026)
52-week high$0.4210
52-week low$0.2636
Median price$0.4210
Average price$0.4173
Largest weekly change+30.2% (Aug 21, 2024)
Weeks tracked132
Tracking sinceFeb 14, 2024

Price History

1W

-11.0%

1M

-11.0%

3M

-20.5%

6M

+6.6%

1Y

-33.3%

3Y

N/A

5Y

N/A

All

-51.9%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FEBUXOSTAT 80 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 80 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2810 per EA (NDC 59651011430), effective Aug 19, 2026.

How has the price of FEBUXOSTAT 80 MG TABLET changed over time?

Over the history we have for it, the NADAC for FEBUXOSTAT 80 MG TABLET has declined 51.9%. It has been tracked across 132 weekly CMS publications since Feb 14, 2024.

What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 80 MG TABLET?

Since Feb 14, 2024, the NADAC for FEBUXOSTAT 80 MG TABLET has ranged from a low of $0.2636 (Feb 18, 2026) to a high of $0.5895 (Nov 13, 2024), with a median of $0.4210 per EA.

Are there cheaper alternatives to FEBUXOSTAT 80 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FEBUXOSTAT 80 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures FEBUXOSTAT 80 MG TABLET?

FEBUXOSTAT 80 MG TABLET (NDC 59651011430) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.